Try our Advanced Search for more refined results
June 9, 2008
Track this case
Gregory M. Sleet
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
A federal judge overseeing the multidistrict litigation arising from Sanofi-Aventis SA’s prostate drug Uroxatral has held that the patent covering the treatment was valid and infringed by Apotex Inc.’s proposed generic copycat.
Already a subscriber? Click here to login